Cramer took some calls:

Alcoa (AA) is doing incredibly well. "You want to own it," especially with a recent acquisition. It usually declines after earnings, so Cramer would consider picking up some then.

GlaxoSmithKline (GSK) has a "murky" pipeline, but it can cover the dividend. "I like Glaxo. I think it is a buy."

ReWalk (RWLK) is "way too hot for me," but Cramer says he needs to do more research before he can opine.

A New Yorker Stock Pick: Agios Pharmaceuticals (NASDAQ:AGIO). Other stocks mentioned: Celgene (NASDAQ:CELG), Myriad Genetics (NASDAQ:MYGN), Tesaro (NASDAQ:TSRO)